Amgen (NASDAQ:AMGN) today announced that new data from its cardiovascular portfolio, including late-breaking results from the Phase 3 VESALIUS-CV clinical trial of Repatha® (evolocumab), will be ...
Capital Market on MSN
Discussion paper highlights proposed changes in housing index compilation methodology in new CPI series
The Ministry of Statistics and Programme Implementation (MoSPI) is undertaking the base revision exercise of the Consumer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback